nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—Topoisomerase Inhibitors—Idarubicin—breast cancer	0.128	0.279	CiPCiCtD
Etoposide—Topoisomerase Inhibitors—Irinotecan—breast cancer	0.108	0.237	CiPCiCtD
Etoposide—Topoisomerase Inhibitors—Mitoxantrone—breast cancer	0.108	0.237	CiPCiCtD
Etoposide—Topoisomerase Inhibitors—Epirubicin—breast cancer	0.0586	0.128	CiPCiCtD
Etoposide—Topoisomerase Inhibitors—Doxorubicin—breast cancer	0.0542	0.119	CiPCiCtD
Etoposide—GSTT1—breast cancer	0.037	0.193	CbGaD
Etoposide—ABCC1—breast cancer	0.0358	0.187	CbGaD
Etoposide—GSTP1—breast cancer	0.0292	0.153	CbGaD
Etoposide—GSTP1—Chlorambucil—breast cancer	0.0277	0.122	CbGbCtD
Etoposide—TOP2A—breast cancer	0.0276	0.145	CbGaD
Etoposide—ABCG2—breast cancer	0.0189	0.0987	CbGaD
Etoposide—PTGS1—breast cancer	0.0162	0.0846	CbGaD
Etoposide—GSTT1—Carboplatin—breast cancer	0.0143	0.063	CbGbCtD
Etoposide—TOP2A—Idarubicin—breast cancer	0.0135	0.0596	CbGbCtD
Etoposide—CYP3A4—breast cancer	0.00944	0.0494	CbGaD
Etoposide—PTGS2—breast cancer	0.00924	0.0483	CbGaD
Etoposide—GSTP1—Carboplatin—breast cancer	0.00894	0.0393	CbGbCtD
Etoposide—ABCB1—breast cancer	0.00786	0.0411	CbGaD
Etoposide—ABCC6—Vinblastine—breast cancer	0.00766	0.0337	CbGbCtD
Etoposide—ABCC1—Idarubicin—breast cancer	0.00751	0.033	CbGbCtD
Etoposide—ABCC10—Gemcitabine—breast cancer	0.00738	0.0325	CbGbCtD
Etoposide—ABCC10—Paclitaxel—breast cancer	0.00667	0.0294	CbGbCtD
Etoposide—TOP2A—Mitoxantrone—breast cancer	0.00582	0.0256	CbGbCtD
Etoposide—ABCC10—Docetaxel—breast cancer	0.00482	0.0212	CbGbCtD
Etoposide—TOP2A—Epirubicin—breast cancer	0.00471	0.0207	CbGbCtD
Etoposide—ABCC6—Doxorubicin—breast cancer	0.00471	0.0207	CbGbCtD
Etoposide—ABCC3—Fluorouracil—breast cancer	0.00397	0.0175	CbGbCtD
Etoposide—ABCC10—Doxorubicin—breast cancer	0.0036	0.0158	CbGbCtD
Etoposide—ABCC10—Methotrexate—breast cancer	0.00348	0.0153	CbGbCtD
Etoposide—ABCC1—Mitoxantrone—breast cancer	0.00323	0.0142	CbGbCtD
Etoposide—UGT1A1—Irinotecan—breast cancer	0.00309	0.0136	CbGbCtD
Etoposide—CYP1A2—Anastrozole—breast cancer	0.00273	0.012	CbGbCtD
Etoposide—ABCC1—Epirubicin—breast cancer	0.00261	0.0115	CbGbCtD
Etoposide—ABCC1—Paclitaxel—breast cancer	0.00258	0.0113	CbGbCtD
Etoposide—ABCC1—Irinotecan—breast cancer	0.00254	0.0112	CbGbCtD
Etoposide—TOP2A—Doxorubicin—breast cancer	0.0025	0.011	CbGbCtD
Etoposide—CYP1A2—Toremifene—breast cancer	0.0025	0.011	CbGbCtD
Etoposide—CYP3A5—Lapatinib—breast cancer	0.00245	0.0108	CbGbCtD
Etoposide—ABCC2—Tamoxifen—breast cancer	0.00245	0.0108	CbGbCtD
Etoposide—CYP2C8—Lapatinib—breast cancer	0.00236	0.0104	CbGbCtD
Etoposide—ABCC3—Doxorubicin—breast cancer	0.00226	0.00995	CbGbCtD
Etoposide—ABCC1—Vinblastine—breast cancer	0.00226	0.00994	CbGbCtD
Etoposide—ABCG2—Tamoxifen—breast cancer	0.00221	0.00974	CbGbCtD
Etoposide—ABCC3—Methotrexate—breast cancer	0.00219	0.00964	CbGbCtD
Etoposide—ABCB1—Toremifene—breast cancer	0.00219	0.00962	CbGbCtD
Etoposide—ABCG2—Mitoxantrone—breast cancer	0.00216	0.0095	CbGbCtD
Etoposide—ABCC2—Paclitaxel—breast cancer	0.00191	0.00839	CbGbCtD
Etoposide—CYP3A4—Exemestane—breast cancer	0.00189	0.00831	CbGbCtD
Etoposide—ABCC2—Irinotecan—breast cancer	0.00188	0.00828	CbGbCtD
Etoposide—ABCC1—Docetaxel—breast cancer	0.00186	0.00819	CbGbCtD
Etoposide—ABCC2—Carboplatin—breast cancer	0.00179	0.00789	CbGbCtD
Etoposide—CYP2C8—Raloxifene—breast cancer	0.00179	0.00786	CbGbCtD
Etoposide—ABCG2—Paclitaxel—breast cancer	0.00172	0.00758	CbGbCtD
Etoposide—ABCG2—Irinotecan—breast cancer	0.0017	0.00748	CbGbCtD
Etoposide—ABCC2—Vinblastine—breast cancer	0.00167	0.00736	CbGbCtD
Etoposide—ABCG2—Fluorouracil—breast cancer	0.00163	0.00718	CbGbCtD
Etoposide—ABCG2—Carboplatin—breast cancer	0.00162	0.00714	CbGbCtD
Etoposide—CYP3A4—Letrozole—breast cancer	0.00161	0.00707	CbGbCtD
Etoposide—ABCB1—Lapatinib—breast cancer	0.00159	0.00702	CbGbCtD
Etoposide—CYP2E1—Tamoxifen—breast cancer	0.00158	0.00695	CbGbCtD
Etoposide—CYP2E1—Mitoxantrone—breast cancer	0.00154	0.00678	CbGbCtD
Etoposide—CYP3A4—Anastrozole—breast cancer	0.00143	0.0063	CbGbCtD
Etoposide—ABCC1—Doxorubicin—breast cancer	0.00139	0.00611	CbGbCtD
Etoposide—ABCC2—Docetaxel—breast cancer	0.00138	0.00606	CbGbCtD
Etoposide—ABCC1—Methotrexate—breast cancer	0.00134	0.00592	CbGbCtD
Etoposide—CYP3A4—Toremifene—breast cancer	0.00131	0.00576	CbGbCtD
Etoposide—ABCG2—Docetaxel—breast cancer	0.00125	0.00548	CbGbCtD
Etoposide—CYP3A5—Tamoxifen—breast cancer	0.00123	0.0054	CbGbCtD
Etoposide—CYP3A4—Fulvestrant—breast cancer	0.00122	0.00536	CbGbCtD
Etoposide—CYP2C8—Tamoxifen—breast cancer	0.00118	0.00519	CbGbCtD
Etoposide—CYP3A4—Thiotepa—breast cancer	0.00109	0.00478	CbGbCtD
Etoposide—ABCC2—Doxorubicin—breast cancer	0.00103	0.00452	CbGbCtD
Etoposide—ABCC2—Methotrexate—breast cancer	0.000995	0.00438	CbGbCtD
Etoposide—CYP3A4—Ixabepilone—breast cancer	0.000993	0.00437	CbGbCtD
Etoposide—CYP3A4—Lapatinib—breast cancer	0.000955	0.0042	CbGbCtD
Etoposide—CYP3A5—Paclitaxel—breast cancer	0.000955	0.0042	CbGbCtD
Etoposide—CYP3A5—Irinotecan—breast cancer	0.000942	0.00415	CbGbCtD
Etoposide—ABCG2—Doxorubicin—breast cancer	0.000929	0.00409	CbGbCtD
Etoposide—CYP2C8—Paclitaxel—breast cancer	0.000918	0.00404	CbGbCtD
Etoposide—CYP1A2—Tamoxifen—breast cancer	0.000913	0.00402	CbGbCtD
Etoposide—ABCG2—Methotrexate—breast cancer	0.0009	0.00396	CbGbCtD
Etoposide—ABCB1—Vinorelbine—breast cancer	0.000885	0.00389	CbGbCtD
Etoposide—CYP2C8—Fluorouracil—breast cancer	0.000869	0.00382	CbGbCtD
Etoposide—Teniposide—NCOA1—breast cancer	0.000824	0.42	CrCbGaD
Etoposide—ABCB1—Tamoxifen—breast cancer	0.000798	0.00351	CbGbCtD
Etoposide—ABCB1—Mitoxantrone—breast cancer	0.000779	0.00343	CbGbCtD
Etoposide—CYP3A4—Raloxifene—breast cancer	0.000724	0.00319	CbGbCtD
Etoposide—CYP3A5—Docetaxel—breast cancer	0.00069	0.00304	CbGbCtD
Etoposide—ABCB1—Gemcitabine—breast cancer	0.000688	0.00303	CbGbCtD
Etoposide—CYP1A2—Fluorouracil—breast cancer	0.000673	0.00296	CbGbCtD
Etoposide—ABCB1—Paclitaxel—breast cancer	0.000621	0.00273	CbGbCtD
Etoposide—ABCB1—Irinotecan—breast cancer	0.000613	0.0027	CbGbCtD
Etoposide—Teniposide—NCOA3—breast cancer	0.000556	0.284	CrCbGaD
Etoposide—ABCB1—Vinblastine—breast cancer	0.000545	0.0024	CbGbCtD
Etoposide—CYP3A4—Vinorelbine—breast cancer	0.00053	0.00233	CbGbCtD
Etoposide—TOP2B—mammary gland—breast cancer	0.000521	0.033	CbGeAlD
Etoposide—CYP3A4—Tamoxifen—breast cancer	0.000478	0.00211	CbGbCtD
Etoposide—CYP3A4—Mitoxantrone—breast cancer	0.000467	0.00205	CbGbCtD
Etoposide—ABCB1—Docetaxel—breast cancer	0.000449	0.00198	CbGbCtD
Etoposide—TOP2B—nipple—breast cancer	0.000431	0.0273	CbGeAlD
Etoposide—CYP3A4—Paclitaxel—breast cancer	0.000372	0.00164	CbGbCtD
Etoposide—TOP2B—Topotecan—Irinotecan—breast cancer	0.000371	0.347	CbGdCrCtD
Etoposide—CYP3A4—Irinotecan—breast cancer	0.000367	0.00162	CbGbCtD
Etoposide—TOP2B—embryo—breast cancer	0.000355	0.0225	CbGeAlD
Etoposide—ABCB1—Doxorubicin—breast cancer	0.000335	0.00147	CbGbCtD
Etoposide—CYP3A4—Vinblastine—breast cancer	0.000327	0.00144	CbGbCtD
Etoposide—ABCB1—Methotrexate—breast cancer	0.000324	0.00143	CbGbCtD
Etoposide—TOP2A—nipple—breast cancer	0.000317	0.02	CbGeAlD
Etoposide—GSTT1—female reproductive system—breast cancer	0.000292	0.0185	CbGeAlD
Etoposide—GSTP1—nipple—breast cancer	0.00027	0.0171	CbGeAlD
Etoposide—ABCC10—nipple—breast cancer	0.00027	0.0171	CbGeAlD
Etoposide—CYP3A4—Docetaxel—breast cancer	0.000269	0.00118	CbGbCtD
Etoposide—TOP2B—endometrium—breast cancer	0.00026	0.0165	CbGeAlD
Etoposide—ABCC6—adipose tissue—breast cancer	0.000258	0.0163	CbGeAlD
Etoposide—GSTT1—endocrine gland—breast cancer	0.000247	0.0157	CbGeAlD
Etoposide—TOP2B—uterus—breast cancer	0.00024	0.0152	CbGeAlD
Etoposide—TOP2B—pituitary gland—breast cancer	0.000235	0.0149	CbGeAlD
Etoposide—TOP2B—adipose tissue—breast cancer	0.000234	0.0148	CbGeAlD
Etoposide—GSTP1—embryo—breast cancer	0.000223	0.0141	CbGeAlD
Etoposide—TOP2B—female reproductive system—breast cancer	0.000215	0.0136	CbGeAlD
Etoposide—TOP2B—adrenal gland—breast cancer	0.00021	0.0133	CbGeAlD
Etoposide—TOP2B—bone marrow—breast cancer	0.000203	0.0129	CbGeAlD
Etoposide—ABCC6—endocrine gland—breast cancer	0.000201	0.0127	CbGeAlD
Etoposide—CYP3A4—Doxorubicin—breast cancer	0.000201	0.000883	CbGbCtD
Etoposide—CYP2C8—mammary gland—breast cancer	0.000196	0.0124	CbGeAlD
Etoposide—TOP2B—female gonad—breast cancer	0.000196	0.0124	CbGeAlD
Etoposide—TOP2A—endometrium—breast cancer	0.000191	0.0121	CbGeAlD
Etoposide—ABCC1—nipple—breast cancer	0.000191	0.0121	CbGeAlD
Etoposide—Podofilox—TOP2A—breast cancer	0.00019	0.0968	CrCbGaD
Etoposide—TOP2B—endocrine gland—breast cancer	0.000182	0.0115	CbGeAlD
Etoposide—GSTP1—epithelium—breast cancer	0.000182	0.0115	CbGeAlD
Etoposide—TOP2A—uterus—breast cancer	0.000176	0.0112	CbGeAlD
Etoposide—GSTP1—skin of body—breast cancer	0.000173	0.0109	CbGeAlD
Etoposide—TOP2A—adipose tissue—breast cancer	0.000172	0.0109	CbGeAlD
Etoposide—GSTP1—endometrium—breast cancer	0.000163	0.0103	CbGeAlD
Etoposide—ABCC10—endometrium—breast cancer	0.000163	0.0103	CbGeAlD
Etoposide—Teniposide—TOP2A—breast cancer	0.000162	0.0823	CrCbGaD
Etoposide—TOP2A—adrenal gland—breast cancer	0.000155	0.00978	CbGeAlD
Etoposide—CYP1A2—nipple—breast cancer	0.000152	0.00962	CbGeAlD
Etoposide—GSTP1—uterus—breast cancer	0.00015	0.0095	CbGeAlD
Etoposide—ABCC10—uterus—breast cancer	0.00015	0.00949	CbGeAlD
Etoposide—TOP2A—bone marrow—breast cancer	0.00015	0.00946	CbGeAlD
Etoposide—ABCC3—adipose tissue—breast cancer	0.000147	0.00933	CbGeAlD
Etoposide—GSTP1—pituitary gland—breast cancer	0.000147	0.00933	CbGeAlD
Etoposide—ABCC10—pituitary gland—breast cancer	0.000147	0.00932	CbGeAlD
Etoposide—GSTP1—adipose tissue—breast cancer	0.000147	0.00929	CbGeAlD
Etoposide—ABCC10—adipose tissue—breast cancer	0.000147	0.00929	CbGeAlD
Etoposide—UGT1A1—endocrine gland—breast cancer	0.000145	0.00919	CbGeAlD
Etoposide—TOP2A—female gonad—breast cancer	0.000144	0.00912	CbGeAlD
Etoposide—ABCC3—female reproductive system—breast cancer	0.000135	0.00858	CbGeAlD
Etoposide—GSTP1—female reproductive system—breast cancer	0.000135	0.00854	CbGeAlD
Etoposide—ABCC10—female reproductive system—breast cancer	0.000135	0.00853	CbGeAlD
Etoposide—ABCC3—adrenal gland—breast cancer	0.000132	0.00837	CbGeAlD
Etoposide—GSTP1—adrenal gland—breast cancer	0.000132	0.00833	CbGeAlD
Etoposide—PTGS1—nipple—breast cancer	0.000132	0.00833	CbGeAlD
Etoposide—ABCC10—adrenal gland—breast cancer	0.000132	0.00833	CbGeAlD
Etoposide—GSTP1—bone marrow—breast cancer	0.000127	0.00806	CbGeAlD
Etoposide—ABCC10—bone marrow—breast cancer	0.000127	0.00806	CbGeAlD
Etoposide—TOP2B—lymph node—breast cancer	0.000126	0.00798	CbGeAlD
Etoposide—ABCC3—female gonad—breast cancer	0.000123	0.0078	CbGeAlD
Etoposide—GSTP1—female gonad—breast cancer	0.000123	0.00777	CbGeAlD
Etoposide—ABCC10—female gonad—breast cancer	0.000123	0.00777	CbGeAlD
Etoposide—ABCC1—endometrium—breast cancer	0.000115	0.00729	CbGeAlD
Etoposide—ABCC3—endocrine gland—breast cancer	0.000115	0.00726	CbGeAlD
Etoposide—GSTP1—endocrine gland—breast cancer	0.000114	0.00723	CbGeAlD
Etoposide—ABCC10—endocrine gland—breast cancer	0.000114	0.00722	CbGeAlD
Etoposide—Teniposide—ABCG2—breast cancer	0.00011	0.0563	CrCbGaD
Etoposide—ABCC2—female reproductive system—breast cancer	0.000108	0.00685	CbGeAlD
Etoposide—ABCC1—uterus—breast cancer	0.000106	0.00672	CbGeAlD
Etoposide—ABCC2—adrenal gland—breast cancer	0.000106	0.00669	CbGeAlD
Etoposide—ABCC1—pituitary gland—breast cancer	0.000104	0.00659	CbGeAlD
Etoposide—PTGS2—embryo—breast cancer	0.000104	0.00657	CbGeAlD
Etoposide—ABCC1—adipose tissue—breast cancer	0.000104	0.00657	CbGeAlD
Etoposide—CYP2C8—endometrium—breast cancer	9.8e-05	0.0062	CbGeAlD
Etoposide—ABCG2—endometrium—breast cancer	9.53e-05	0.00603	CbGeAlD
Etoposide—ABCC1—adrenal gland—breast cancer	9.31e-05	0.00589	CbGeAlD
Etoposide—TOP2A—lymph node—breast cancer	9.26e-05	0.00586	CbGeAlD
Etoposide—ABCC2—endocrine gland—breast cancer	9.16e-05	0.0058	CbGeAlD
Etoposide—CYP2C8—pituitary gland—breast cancer	8.87e-05	0.00561	CbGeAlD
Etoposide—PTGS1—epithelium—breast cancer	8.86e-05	0.00561	CbGeAlD
Etoposide—ABCG2—uterus—breast cancer	8.78e-05	0.00556	CbGeAlD
Etoposide—ABCC1—female gonad—breast cancer	8.68e-05	0.00549	CbGeAlD
Etoposide—ABCG2—pituitary gland—breast cancer	8.62e-05	0.00546	CbGeAlD
Etoposide—ABCG2—adipose tissue—breast cancer	8.59e-05	0.00544	CbGeAlD
Etoposide—PTGS2—epithelium—breast cancer	8.47e-05	0.00536	CbGeAlD
Etoposide—PTGS1—skin of body—breast cancer	8.43e-05	0.00534	CbGeAlD
Etoposide—TOP2A—Docetaxel—Paclitaxel—breast cancer	8.42e-05	0.0787	CbGdCrCtD
Etoposide—TOP2A—Gefitinib—Lapatinib—breast cancer	8.26e-05	0.0772	CbGdCrCtD
Etoposide—CYP2C8—female reproductive system—breast cancer	8.12e-05	0.00514	CbGeAlD
Etoposide—PTGS2—skin of body—breast cancer	8.06e-05	0.0051	CbGeAlD
Etoposide—CYP3A5—adipose tissue—breast cancer	7.97e-05	0.00505	CbGeAlD
Etoposide—PTGS1—endometrium—breast cancer	7.95e-05	0.00503	CbGeAlD
Etoposide—ABCC3—lymph node—breast cancer	7.93e-05	0.00502	CbGeAlD
Etoposide—GSTP1—lymph node—breast cancer	7.89e-05	0.005	CbGeAlD
Etoposide—ABCC10—lymph node—breast cancer	7.89e-05	0.00499	CbGeAlD
Etoposide—ABCG2—adrenal gland—breast cancer	7.7e-05	0.00488	CbGeAlD
Etoposide—PTGS2—endometrium—breast cancer	7.6e-05	0.00481	CbGeAlD
Etoposide—ABCG2—bone marrow—breast cancer	7.45e-05	0.00472	CbGeAlD
Etoposide—PTGS1—uterus—breast cancer	7.32e-05	0.00464	CbGeAlD
Etoposide—PTGS1—pituitary gland—breast cancer	7.19e-05	0.00455	CbGeAlD
Etoposide—ABCG2—female gonad—breast cancer	7.18e-05	0.00455	CbGeAlD
Etoposide—PTGS1—adipose tissue—breast cancer	7.16e-05	0.00453	CbGeAlD
Etoposide—PTGS2—uterus—breast cancer	7e-05	0.00443	CbGeAlD
Etoposide—PTGS2—pituitary gland—breast cancer	6.87e-05	0.00435	CbGeAlD
Etoposide—CYP2C8—endocrine gland—breast cancer	6.87e-05	0.00435	CbGeAlD
Etoposide—PTGS2—adipose tissue—breast cancer	6.85e-05	0.00433	CbGeAlD
Etoposide—CYP2E1—female reproductive system—breast cancer	6.83e-05	0.00433	CbGeAlD
Etoposide—CYP2E1—adrenal gland—breast cancer	6.67e-05	0.00422	CbGeAlD
Etoposide—CYP3A5—female gonad—breast cancer	6.67e-05	0.00422	CbGeAlD
Etoposide—PTGS1—female reproductive system—breast cancer	6.58e-05	0.00417	CbGeAlD
Etoposide—Podofilox—CYP3A4—breast cancer	6.49e-05	0.0331	CrCbGaD
Etoposide—CYP1A2—endocrine gland—breast cancer	6.43e-05	0.00407	CbGeAlD
Etoposide—PTGS1—adrenal gland—breast cancer	6.43e-05	0.00407	CbGeAlD
Etoposide—ABCB1—embryo—breast cancer	6.42e-05	0.00407	CbGeAlD
Etoposide—ABCC2—lymph node—breast cancer	6.33e-05	0.00401	CbGeAlD
Etoposide—PTGS2—female reproductive system—breast cancer	6.29e-05	0.00398	CbGeAlD
Etoposide—CYP3A5—endocrine gland—breast cancer	6.2e-05	0.00393	CbGeAlD
Etoposide—PTGS2—adrenal gland—breast cancer	6.14e-05	0.00389	CbGeAlD
Etoposide—TOP2A—Topotecan—Irinotecan—breast cancer	5.99e-05	0.056	CbGdCrCtD
Etoposide—PTGS1—female gonad—breast cancer	5.99e-05	0.00379	CbGeAlD
Etoposide—PTGS2—bone marrow—breast cancer	5.94e-05	0.00376	CbGeAlD
Etoposide—CYP2E1—endocrine gland—breast cancer	5.78e-05	0.00366	CbGeAlD
Etoposide—PTGS2—female gonad—breast cancer	5.73e-05	0.00363	CbGeAlD
Etoposide—ABCC1—lymph node—breast cancer	5.58e-05	0.00353	CbGeAlD
Etoposide—PTGS1—endocrine gland—breast cancer	5.57e-05	0.00353	CbGeAlD
Etoposide—Teniposide—CYP3A4—breast cancer	5.52e-05	0.0281	CrCbGaD
Etoposide—CYP3A4—female reproductive system—breast cancer	5.5e-05	0.00348	CbGeAlD
Etoposide—TOP2A—Vindesine—Vinorelbine—breast cancer	5.36e-05	0.0501	CbGdCrCtD
Etoposide—PTGS2—endocrine gland—breast cancer	5.33e-05	0.00337	CbGeAlD
Etoposide—ABCB1—epithelium—breast cancer	5.24e-05	0.00332	CbGeAlD
Etoposide—ABCB1—endometrium—breast cancer	4.7e-05	0.00297	CbGeAlD
Etoposide—CYP3A4—endocrine gland—breast cancer	4.65e-05	0.00295	CbGeAlD
Etoposide—ABCG2—lymph node—breast cancer	4.62e-05	0.00292	CbGeAlD
Etoposide—ABCB1—uterus—breast cancer	4.33e-05	0.00274	CbGeAlD
Etoposide—TOP2A—Vindesine—Vinblastine—breast cancer	4.28e-05	0.04	CbGdCrCtD
Etoposide—ABCB1—pituitary gland—breast cancer	4.25e-05	0.00269	CbGeAlD
Etoposide—ABCB1—adipose tissue—breast cancer	4.24e-05	0.00268	CbGeAlD
Etoposide—TOP2A—Paclitaxel—Docetaxel—breast cancer	4.2e-05	0.0393	CbGdCrCtD
Etoposide—ABCB1—female reproductive system—breast cancer	3.89e-05	0.00246	CbGeAlD
Etoposide—PTGS1—lymph node—breast cancer	3.85e-05	0.00244	CbGeAlD
Etoposide—ABCB1—adrenal gland—breast cancer	3.8e-05	0.0024	CbGeAlD
Etoposide—PTGS2—lymph node—breast cancer	3.68e-05	0.00233	CbGeAlD
Etoposide—ABCB1—bone marrow—breast cancer	3.68e-05	0.00233	CbGeAlD
Etoposide—ABCB1—female gonad—breast cancer	3.54e-05	0.00224	CbGeAlD
Etoposide—ABCB1—endocrine gland—breast cancer	3.29e-05	0.00209	CbGeAlD
Etoposide—TOP2A—Doxorubicin—Idarubicin—breast cancer	3.07e-05	0.0287	CbGdCrCtD
Etoposide—TOP2A—Epirubicin—Idarubicin—breast cancer	3.07e-05	0.0287	CbGdCrCtD
Etoposide—TOP2A—Daunorubicin—Idarubicin—breast cancer	3.07e-05	0.0287	CbGdCrCtD
Etoposide—TOP2A—Vincristine—Vinorelbine—breast cancer	2.89e-05	0.027	CbGdCrCtD
Etoposide—TOP2A—Vinorelbine—Vinblastine—breast cancer	2.7e-05	0.0253	CbGdCrCtD
Etoposide—TOP2A—Vinblastine—Vinorelbine—breast cancer	2.32e-05	0.0217	CbGdCrCtD
Etoposide—TOP2A—Vincristine—Vinblastine—breast cancer	2.31e-05	0.0216	CbGdCrCtD
Etoposide—ABCB1—lymph node—breast cancer	2.28e-05	0.00144	CbGeAlD
Etoposide—TOP2A—Methyltestosterone—Fluoxymesterone—breast cancer	1.95e-05	0.0182	CbGdCrCtD
Etoposide—TOP2A—Cytarabine—Gemcitabine—breast cancer	1.52e-05	0.0142	CbGdCrCtD
Etoposide—TOP2A—Doxorubicin—Epirubicin—breast cancer	1.41e-05	0.0132	CbGdCrCtD
Etoposide—TOP2A—Idarubicin—Epirubicin—breast cancer	1.41e-05	0.0132	CbGdCrCtD
Etoposide—TOP2A—Daunorubicin—Epirubicin—breast cancer	1.41e-05	0.0132	CbGdCrCtD
Etoposide—TOP2A—Idarubicin—Doxorubicin—breast cancer	1.3e-05	0.0122	CbGdCrCtD
Etoposide—TOP2A—Daunorubicin—Doxorubicin—breast cancer	1.3e-05	0.0122	CbGdCrCtD
Etoposide—TOP2A—Epirubicin—Doxorubicin—breast cancer	1.3e-05	0.0122	CbGdCrCtD
Etoposide—TOP2A—Norethindrone—Fluoxymesterone—breast cancer	1.27e-05	0.0119	CbGdCrCtD
Etoposide—TOP2A—Azacitidine—Gemcitabine—breast cancer	1.09e-05	0.0102	CbGdCrCtD
Etoposide—Cardiac disorder—Methotrexate—breast cancer	9.71e-06	0.000146	CcSEcCtD
Etoposide—Skin disorder—Capecitabine—breast cancer	9.7e-06	0.000146	CcSEcCtD
Etoposide—Urinary tract disorder—Epirubicin—breast cancer	9.67e-06	0.000145	CcSEcCtD
Etoposide—Urticaria—Paclitaxel—breast cancer	9.67e-06	0.000145	CcSEcCtD
Etoposide—Hyperhidrosis—Capecitabine—breast cancer	9.66e-06	0.000145	CcSEcCtD
Etoposide—Hypotension—Docetaxel—breast cancer	9.64e-06	0.000145	CcSEcCtD
Etoposide—Abdominal pain—Paclitaxel—breast cancer	9.62e-06	0.000145	CcSEcCtD
Etoposide—Body temperature increased—Paclitaxel—breast cancer	9.62e-06	0.000145	CcSEcCtD
Etoposide—Urethral disorder—Epirubicin—breast cancer	9.6e-06	0.000144	CcSEcCtD
Etoposide—Hepatobiliary disease—Doxorubicin—breast cancer	9.55e-06	0.000144	CcSEcCtD
Etoposide—Anorexia—Capecitabine—breast cancer	9.52e-06	0.000143	CcSEcCtD
Etoposide—Angiopathy—Methotrexate—breast cancer	9.5e-06	0.000143	CcSEcCtD
Etoposide—Vomiting—Irinotecan—breast cancer	9.49e-06	0.000143	CcSEcCtD
Etoposide—Vomiting—Mitoxantrone—breast cancer	9.49e-06	0.000143	CcSEcCtD
Etoposide—Immune system disorder—Methotrexate—breast cancer	9.45e-06	0.000142	CcSEcCtD
Etoposide—Dizziness—Fluorouracil—breast cancer	9.45e-06	0.000142	CcSEcCtD
Etoposide—Mediastinal disorder—Methotrexate—breast cancer	9.43e-06	0.000142	CcSEcCtD
Etoposide—Agranulocytosis—Doxorubicin—breast cancer	9.42e-06	0.000142	CcSEcCtD
Etoposide—Rash—Mitoxantrone—breast cancer	9.41e-06	0.000142	CcSEcCtD
Etoposide—Rash—Irinotecan—breast cancer	9.41e-06	0.000142	CcSEcCtD
Etoposide—Dermatitis—Mitoxantrone—breast cancer	9.4e-06	0.000141	CcSEcCtD
Etoposide—Dermatitis—Irinotecan—breast cancer	9.4e-06	0.000141	CcSEcCtD
Etoposide—Chills—Methotrexate—breast cancer	9.39e-06	0.000141	CcSEcCtD
Etoposide—Headache—Mitoxantrone—breast cancer	9.35e-06	0.000141	CcSEcCtD
Etoposide—Headache—Irinotecan—breast cancer	9.35e-06	0.000141	CcSEcCtD
Etoposide—Hypotension—Capecitabine—breast cancer	9.33e-06	0.00014	CcSEcCtD
Etoposide—Paraesthesia—Docetaxel—breast cancer	9.26e-06	0.000139	CcSEcCtD
Etoposide—Erythema multiforme—Epirubicin—breast cancer	9.26e-06	0.000139	CcSEcCtD
Etoposide—Alopecia—Methotrexate—breast cancer	9.25e-06	0.000139	CcSEcCtD
Etoposide—Vomiting—Gemcitabine—breast cancer	9.24e-06	0.000139	CcSEcCtD
Etoposide—Dyspnoea—Docetaxel—breast cancer	9.2e-06	0.000138	CcSEcCtD
Etoposide—Somnolence—Docetaxel—breast cancer	9.17e-06	0.000138	CcSEcCtD
Etoposide—Rash—Gemcitabine—breast cancer	9.17e-06	0.000138	CcSEcCtD
Etoposide—Dermatitis—Gemcitabine—breast cancer	9.16e-06	0.000138	CcSEcCtD
Etoposide—Eye disorder—Epirubicin—breast cancer	9.15e-06	0.000138	CcSEcCtD
Etoposide—Headache—Gemcitabine—breast cancer	9.11e-06	0.000137	CcSEcCtD
Etoposide—Flushing—Epirubicin—breast cancer	9.09e-06	0.000137	CcSEcCtD
Etoposide—Cardiac disorder—Epirubicin—breast cancer	9.09e-06	0.000137	CcSEcCtD
Etoposide—Vomiting—Fluorouracil—breast cancer	9.09e-06	0.000137	CcSEcCtD
Etoposide—Hypoaesthesia—Doxorubicin—breast cancer	9.02e-06	0.000136	CcSEcCtD
Etoposide—Rash—Fluorouracil—breast cancer	9.01e-06	0.000136	CcSEcCtD
Etoposide—Dermatitis—Fluorouracil—breast cancer	9e-06	0.000135	CcSEcCtD
Etoposide—Paraesthesia—Capecitabine—breast cancer	8.97e-06	0.000135	CcSEcCtD
Etoposide—Decreased appetite—Docetaxel—breast cancer	8.97e-06	0.000135	CcSEcCtD
Etoposide—Hypersensitivity—Paclitaxel—breast cancer	8.97e-06	0.000135	CcSEcCtD
Etoposide—Headache—Fluorouracil—breast cancer	8.95e-06	0.000135	CcSEcCtD
Etoposide—Urinary tract disorder—Doxorubicin—breast cancer	8.95e-06	0.000135	CcSEcCtD
Etoposide—Dysgeusia—Methotrexate—breast cancer	8.92e-06	0.000134	CcSEcCtD
Etoposide—Gastrointestinal disorder—Docetaxel—breast cancer	8.91e-06	0.000134	CcSEcCtD
Etoposide—Dyspnoea—Capecitabine—breast cancer	8.91e-06	0.000134	CcSEcCtD
Etoposide—Fatigue—Docetaxel—breast cancer	8.89e-06	0.000134	CcSEcCtD
Etoposide—Angiopathy—Epirubicin—breast cancer	8.89e-06	0.000134	CcSEcCtD
Etoposide—Urethral disorder—Doxorubicin—breast cancer	8.88e-06	0.000134	CcSEcCtD
Etoposide—Nausea—Irinotecan—breast cancer	8.86e-06	0.000133	CcSEcCtD
Etoposide—Nausea—Mitoxantrone—breast cancer	8.86e-06	0.000133	CcSEcCtD
Etoposide—Immune system disorder—Epirubicin—breast cancer	8.85e-06	0.000133	CcSEcCtD
Etoposide—Mediastinal disorder—Epirubicin—breast cancer	8.83e-06	0.000133	CcSEcCtD
Etoposide—Constipation—Docetaxel—breast cancer	8.82e-06	0.000133	CcSEcCtD
Etoposide—Pain—Docetaxel—breast cancer	8.82e-06	0.000133	CcSEcCtD
Etoposide—Back pain—Methotrexate—breast cancer	8.81e-06	0.000133	CcSEcCtD
Etoposide—Chills—Epirubicin—breast cancer	8.79e-06	0.000132	CcSEcCtD
Etoposide—Asthenia—Paclitaxel—breast cancer	8.73e-06	0.000131	CcSEcCtD
Etoposide—Decreased appetite—Capecitabine—breast cancer	8.68e-06	0.000131	CcSEcCtD
Etoposide—Alopecia—Epirubicin—breast cancer	8.66e-06	0.00013	CcSEcCtD
Etoposide—Nausea—Gemcitabine—breast cancer	8.64e-06	0.00013	CcSEcCtD
Etoposide—Gastrointestinal disorder—Capecitabine—breast cancer	8.62e-06	0.00013	CcSEcCtD
Etoposide—Fatigue—Capecitabine—breast cancer	8.61e-06	0.00013	CcSEcCtD
Etoposide—Pruritus—Paclitaxel—breast cancer	8.61e-06	0.00013	CcSEcCtD
Etoposide—Erythema multiforme—Doxorubicin—breast cancer	8.57e-06	0.000129	CcSEcCtD
Etoposide—Pain—Capecitabine—breast cancer	8.54e-06	0.000128	CcSEcCtD
Etoposide—Constipation—Capecitabine—breast cancer	8.54e-06	0.000128	CcSEcCtD
Etoposide—Feeling abnormal—Docetaxel—breast cancer	8.5e-06	0.000128	CcSEcCtD
Etoposide—Nausea—Fluorouracil—breast cancer	8.49e-06	0.000128	CcSEcCtD
Etoposide—Eye disorder—Doxorubicin—breast cancer	8.47e-06	0.000127	CcSEcCtD
Etoposide—Ill-defined disorder—Methotrexate—breast cancer	8.45e-06	0.000127	CcSEcCtD
Etoposide—Gastrointestinal pain—Docetaxel—breast cancer	8.44e-06	0.000127	CcSEcCtD
Etoposide—Anaemia—Methotrexate—breast cancer	8.42e-06	0.000127	CcSEcCtD
Etoposide—Cardiac disorder—Doxorubicin—breast cancer	8.41e-06	0.000127	CcSEcCtD
Etoposide—Flushing—Doxorubicin—breast cancer	8.41e-06	0.000127	CcSEcCtD
Etoposide—Dysgeusia—Epirubicin—breast cancer	8.35e-06	0.000126	CcSEcCtD
Etoposide—Diarrhoea—Paclitaxel—breast cancer	8.33e-06	0.000125	CcSEcCtD
Etoposide—Back pain—Epirubicin—breast cancer	8.25e-06	0.000124	CcSEcCtD
Etoposide—Feeling abnormal—Capecitabine—breast cancer	8.23e-06	0.000124	CcSEcCtD
Etoposide—Angiopathy—Doxorubicin—breast cancer	8.22e-06	0.000124	CcSEcCtD
Etoposide—Malaise—Methotrexate—breast cancer	8.22e-06	0.000124	CcSEcCtD
Etoposide—Muscle spasms—Epirubicin—breast cancer	8.2e-06	0.000123	CcSEcCtD
Etoposide—Immune system disorder—Doxorubicin—breast cancer	8.19e-06	0.000123	CcSEcCtD
Etoposide—Vertigo—Methotrexate—breast cancer	8.19e-06	0.000123	CcSEcCtD
Etoposide—Gastrointestinal pain—Capecitabine—breast cancer	8.17e-06	0.000123	CcSEcCtD
Etoposide—Mediastinal disorder—Doxorubicin—breast cancer	8.17e-06	0.000123	CcSEcCtD
Etoposide—Body temperature increased—Docetaxel—breast cancer	8.16e-06	0.000123	CcSEcCtD
Etoposide—Abdominal pain—Docetaxel—breast cancer	8.16e-06	0.000123	CcSEcCtD
Etoposide—Leukopenia—Methotrexate—breast cancer	8.16e-06	0.000123	CcSEcCtD
Etoposide—Chills—Doxorubicin—breast cancer	8.13e-06	0.000122	CcSEcCtD
Etoposide—Dizziness—Paclitaxel—breast cancer	8.05e-06	0.000121	CcSEcCtD
Etoposide—Alopecia—Doxorubicin—breast cancer	8.01e-06	0.00012	CcSEcCtD
Etoposide—Cough—Methotrexate—breast cancer	7.95e-06	0.00012	CcSEcCtD
Etoposide—Urticaria—Capecitabine—breast cancer	7.94e-06	0.000119	CcSEcCtD
Etoposide—Ill-defined disorder—Epirubicin—breast cancer	7.91e-06	0.000119	CcSEcCtD
Etoposide—Abdominal pain—Capecitabine—breast cancer	7.9e-06	0.000119	CcSEcCtD
Etoposide—Body temperature increased—Capecitabine—breast cancer	7.9e-06	0.000119	CcSEcCtD
Etoposide—Convulsion—Methotrexate—breast cancer	7.89e-06	0.000119	CcSEcCtD
Etoposide—Anaemia—Epirubicin—breast cancer	7.88e-06	0.000119	CcSEcCtD
Etoposide—Chest pain—Methotrexate—breast cancer	7.76e-06	0.000117	CcSEcCtD
Etoposide—Vomiting—Paclitaxel—breast cancer	7.74e-06	0.000116	CcSEcCtD
Etoposide—Dysgeusia—Doxorubicin—breast cancer	7.73e-06	0.000116	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	7.7e-06	0.000116	CcSEcCtD
Etoposide—Malaise—Epirubicin—breast cancer	7.69e-06	0.000116	CcSEcCtD
Etoposide—Rash—Paclitaxel—breast cancer	7.67e-06	0.000115	CcSEcCtD
Etoposide—Dermatitis—Paclitaxel—breast cancer	7.67e-06	0.000115	CcSEcCtD
Etoposide—Discomfort—Methotrexate—breast cancer	7.66e-06	0.000115	CcSEcCtD
Etoposide—Vertigo—Epirubicin—breast cancer	7.66e-06	0.000115	CcSEcCtD
Etoposide—Leukopenia—Epirubicin—breast cancer	7.63e-06	0.000115	CcSEcCtD
Etoposide—Back pain—Doxorubicin—breast cancer	7.63e-06	0.000115	CcSEcCtD
Etoposide—Headache—Paclitaxel—breast cancer	7.63e-06	0.000115	CcSEcCtD
Etoposide—Hypersensitivity—Docetaxel—breast cancer	7.6e-06	0.000114	CcSEcCtD
Etoposide—Muscle spasms—Doxorubicin—breast cancer	7.58e-06	0.000114	CcSEcCtD
Etoposide—Confusional state—Methotrexate—breast cancer	7.5e-06	0.000113	CcSEcCtD
Etoposide—Loss of consciousness—Epirubicin—breast cancer	7.49e-06	0.000113	CcSEcCtD
Etoposide—Cough—Epirubicin—breast cancer	7.44e-06	0.000112	CcSEcCtD
Etoposide—Anaphylactic shock—Methotrexate—breast cancer	7.44e-06	0.000112	CcSEcCtD
Etoposide—Asthenia—Docetaxel—breast cancer	7.4e-06	0.000111	CcSEcCtD
Etoposide—Convulsion—Epirubicin—breast cancer	7.39e-06	0.000111	CcSEcCtD
Etoposide—Infection—Methotrexate—breast cancer	7.39e-06	0.000111	CcSEcCtD
Etoposide—Hypertension—Epirubicin—breast cancer	7.36e-06	0.000111	CcSEcCtD
Etoposide—Hypersensitivity—Capecitabine—breast cancer	7.36e-06	0.000111	CcSEcCtD
Etoposide—Ill-defined disorder—Doxorubicin—breast cancer	7.32e-06	0.00011	CcSEcCtD
Etoposide—Pruritus—Docetaxel—breast cancer	7.3e-06	0.00011	CcSEcCtD
Etoposide—Anaemia—Doxorubicin—breast cancer	7.29e-06	0.00011	CcSEcCtD
Etoposide—Thrombocytopenia—Methotrexate—breast cancer	7.28e-06	0.00011	CcSEcCtD
Etoposide—Chest pain—Epirubicin—breast cancer	7.26e-06	0.000109	CcSEcCtD
Etoposide—Nausea—Paclitaxel—breast cancer	7.23e-06	0.000109	CcSEcCtD
Etoposide—Skin disorder—Methotrexate—breast cancer	7.22e-06	0.000109	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	7.21e-06	0.000108	CcSEcCtD
Etoposide—Hyperhidrosis—Methotrexate—breast cancer	7.19e-06	0.000108	CcSEcCtD
Etoposide—Discomfort—Epirubicin—breast cancer	7.17e-06	0.000108	CcSEcCtD
Etoposide—Asthenia—Capecitabine—breast cancer	7.17e-06	0.000108	CcSEcCtD
Etoposide—Malaise—Doxorubicin—breast cancer	7.11e-06	0.000107	CcSEcCtD
Etoposide—Vertigo—Doxorubicin—breast cancer	7.09e-06	0.000107	CcSEcCtD
Etoposide—Anorexia—Methotrexate—breast cancer	7.09e-06	0.000107	CcSEcCtD
Etoposide—Pruritus—Capecitabine—breast cancer	7.07e-06	0.000106	CcSEcCtD
Etoposide—Leukopenia—Doxorubicin—breast cancer	7.06e-06	0.000106	CcSEcCtD
Etoposide—Diarrhoea—Docetaxel—breast cancer	7.06e-06	0.000106	CcSEcCtD
Etoposide—Confusional state—Epirubicin—breast cancer	7.02e-06	0.000106	CcSEcCtD
Etoposide—Anaphylactic shock—Epirubicin—breast cancer	6.96e-06	0.000105	CcSEcCtD
Etoposide—Hypotension—Methotrexate—breast cancer	6.95e-06	0.000105	CcSEcCtD
Etoposide—Loss of consciousness—Doxorubicin—breast cancer	6.93e-06	0.000104	CcSEcCtD
Etoposide—Infection—Epirubicin—breast cancer	6.91e-06	0.000104	CcSEcCtD
Etoposide—Cough—Doxorubicin—breast cancer	6.88e-06	0.000104	CcSEcCtD
Etoposide—Convulsion—Doxorubicin—breast cancer	6.84e-06	0.000103	CcSEcCtD
Etoposide—Diarrhoea—Capecitabine—breast cancer	6.83e-06	0.000103	CcSEcCtD
Etoposide—Dizziness—Docetaxel—breast cancer	6.82e-06	0.000103	CcSEcCtD
Etoposide—Thrombocytopenia—Epirubicin—breast cancer	6.81e-06	0.000102	CcSEcCtD
Etoposide—Hypertension—Doxorubicin—breast cancer	6.81e-06	0.000102	CcSEcCtD
Etoposide—Tachycardia—Epirubicin—breast cancer	6.79e-06	0.000102	CcSEcCtD
Etoposide—Skin disorder—Epirubicin—breast cancer	6.76e-06	0.000102	CcSEcCtD
Etoposide—Hyperhidrosis—Epirubicin—breast cancer	6.73e-06	0.000101	CcSEcCtD
Etoposide—Chest pain—Doxorubicin—breast cancer	6.72e-06	0.000101	CcSEcCtD
Etoposide—Paraesthesia—Methotrexate—breast cancer	6.68e-06	0.0001	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	6.67e-06	0.0001	CcSEcCtD
Etoposide—Discomfort—Doxorubicin—breast cancer	6.64e-06	9.98e-05	CcSEcCtD
Etoposide—Anorexia—Epirubicin—breast cancer	6.63e-06	9.98e-05	CcSEcCtD
Etoposide—Dyspnoea—Methotrexate—breast cancer	6.63e-06	9.97e-05	CcSEcCtD
Etoposide—Somnolence—Methotrexate—breast cancer	6.61e-06	9.94e-05	CcSEcCtD
Etoposide—Dizziness—Capecitabine—breast cancer	6.61e-06	9.94e-05	CcSEcCtD
Etoposide—Vomiting—Docetaxel—breast cancer	6.56e-06	9.87e-05	CcSEcCtD
Etoposide—Rash—Docetaxel—breast cancer	6.5e-06	9.78e-05	CcSEcCtD
Etoposide—Hypotension—Epirubicin—breast cancer	6.5e-06	9.78e-05	CcSEcCtD
Etoposide—Dermatitis—Docetaxel—breast cancer	6.5e-06	9.78e-05	CcSEcCtD
Etoposide—Confusional state—Doxorubicin—breast cancer	6.49e-06	9.77e-05	CcSEcCtD
Etoposide—Decreased appetite—Methotrexate—breast cancer	6.46e-06	9.72e-05	CcSEcCtD
Etoposide—Headache—Docetaxel—breast cancer	6.46e-06	9.72e-05	CcSEcCtD
Etoposide—Anaphylactic shock—Doxorubicin—breast cancer	6.44e-06	9.69e-05	CcSEcCtD
Etoposide—Gastrointestinal disorder—Methotrexate—breast cancer	6.42e-06	9.66e-05	CcSEcCtD
Etoposide—Fatigue—Methotrexate—breast cancer	6.41e-06	9.64e-05	CcSEcCtD
Etoposide—Infection—Doxorubicin—breast cancer	6.4e-06	9.62e-05	CcSEcCtD
Etoposide—Pain—Methotrexate—breast cancer	6.36e-06	9.56e-05	CcSEcCtD
Etoposide—Vomiting—Capecitabine—breast cancer	6.35e-06	9.55e-05	CcSEcCtD
Etoposide—Thrombocytopenia—Doxorubicin—breast cancer	6.3e-06	9.48e-05	CcSEcCtD
Etoposide—Rash—Capecitabine—breast cancer	6.3e-06	9.47e-05	CcSEcCtD
Etoposide—Dermatitis—Capecitabine—breast cancer	6.29e-06	9.46e-05	CcSEcCtD
Etoposide—Tachycardia—Doxorubicin—breast cancer	6.28e-06	9.45e-05	CcSEcCtD
Etoposide—Headache—Capecitabine—breast cancer	6.26e-06	9.41e-05	CcSEcCtD
Etoposide—Skin disorder—Doxorubicin—breast cancer	6.25e-06	9.41e-05	CcSEcCtD
Etoposide—Paraesthesia—Epirubicin—breast cancer	6.25e-06	9.4e-05	CcSEcCtD
Etoposide—Hyperhidrosis—Doxorubicin—breast cancer	6.22e-06	9.36e-05	CcSEcCtD
Etoposide—Dyspnoea—Epirubicin—breast cancer	6.2e-06	9.33e-05	CcSEcCtD
Etoposide—Somnolence—Epirubicin—breast cancer	6.19e-06	9.31e-05	CcSEcCtD
Etoposide—Anorexia—Doxorubicin—breast cancer	6.14e-06	9.23e-05	CcSEcCtD
Etoposide—Nausea—Docetaxel—breast cancer	6.13e-06	9.22e-05	CcSEcCtD
Etoposide—Feeling abnormal—Methotrexate—breast cancer	6.13e-06	9.22e-05	CcSEcCtD
Etoposide—Gastrointestinal pain—Methotrexate—breast cancer	6.08e-06	9.15e-05	CcSEcCtD
Etoposide—Decreased appetite—Epirubicin—breast cancer	6.05e-06	9.1e-05	CcSEcCtD
Etoposide—Hypotension—Doxorubicin—breast cancer	6.02e-06	9.05e-05	CcSEcCtD
Etoposide—Gastrointestinal disorder—Epirubicin—breast cancer	6.01e-06	9.04e-05	CcSEcCtD
Etoposide—Fatigue—Epirubicin—breast cancer	6e-06	9.02e-05	CcSEcCtD
Etoposide—Pain—Epirubicin—breast cancer	5.95e-06	8.95e-05	CcSEcCtD
Etoposide—Constipation—Epirubicin—breast cancer	5.95e-06	8.95e-05	CcSEcCtD
Etoposide—Nausea—Capecitabine—breast cancer	5.93e-06	8.92e-05	CcSEcCtD
Etoposide—Urticaria—Methotrexate—breast cancer	5.91e-06	8.89e-05	CcSEcCtD
Etoposide—Abdominal pain—Methotrexate—breast cancer	5.88e-06	8.84e-05	CcSEcCtD
Etoposide—Body temperature increased—Methotrexate—breast cancer	5.88e-06	8.84e-05	CcSEcCtD
Etoposide—Paraesthesia—Doxorubicin—breast cancer	5.78e-06	8.7e-05	CcSEcCtD
Etoposide—Dyspnoea—Doxorubicin—breast cancer	5.74e-06	8.63e-05	CcSEcCtD
Etoposide—Feeling abnormal—Epirubicin—breast cancer	5.73e-06	8.63e-05	CcSEcCtD
Etoposide—Somnolence—Doxorubicin—breast cancer	5.72e-06	8.61e-05	CcSEcCtD
Etoposide—Gastrointestinal pain—Epirubicin—breast cancer	5.69e-06	8.56e-05	CcSEcCtD
Etoposide—Decreased appetite—Doxorubicin—breast cancer	5.6e-06	8.42e-05	CcSEcCtD
Etoposide—Gastrointestinal disorder—Doxorubicin—breast cancer	5.56e-06	8.36e-05	CcSEcCtD
Etoposide—Fatigue—Doxorubicin—breast cancer	5.55e-06	8.35e-05	CcSEcCtD
Etoposide—Urticaria—Epirubicin—breast cancer	5.53e-06	8.32e-05	CcSEcCtD
Etoposide—Pain—Doxorubicin—breast cancer	5.51e-06	8.28e-05	CcSEcCtD
Etoposide—Constipation—Doxorubicin—breast cancer	5.51e-06	8.28e-05	CcSEcCtD
Etoposide—Body temperature increased—Epirubicin—breast cancer	5.5e-06	8.27e-05	CcSEcCtD
Etoposide—Abdominal pain—Epirubicin—breast cancer	5.5e-06	8.27e-05	CcSEcCtD
Etoposide—Hypersensitivity—Methotrexate—breast cancer	5.48e-06	8.24e-05	CcSEcCtD
Etoposide—Asthenia—Methotrexate—breast cancer	5.34e-06	8.02e-05	CcSEcCtD
Etoposide—Feeling abnormal—Doxorubicin—breast cancer	5.31e-06	7.98e-05	CcSEcCtD
Etoposide—Gastrointestinal pain—Doxorubicin—breast cancer	5.27e-06	7.92e-05	CcSEcCtD
Etoposide—Pruritus—Methotrexate—breast cancer	5.26e-06	7.91e-05	CcSEcCtD
Etoposide—Hypersensitivity—Epirubicin—breast cancer	5.13e-06	7.71e-05	CcSEcCtD
Etoposide—Urticaria—Doxorubicin—breast cancer	5.12e-06	7.69e-05	CcSEcCtD
Etoposide—Abdominal pain—Doxorubicin—breast cancer	5.09e-06	7.66e-05	CcSEcCtD
Etoposide—Body temperature increased—Doxorubicin—breast cancer	5.09e-06	7.66e-05	CcSEcCtD
Etoposide—Diarrhoea—Methotrexate—breast cancer	5.09e-06	7.65e-05	CcSEcCtD
Etoposide—Asthenia—Epirubicin—breast cancer	4.99e-06	7.51e-05	CcSEcCtD
Etoposide—Pruritus—Epirubicin—breast cancer	4.92e-06	7.41e-05	CcSEcCtD
Etoposide—Dizziness—Methotrexate—breast cancer	4.92e-06	7.4e-05	CcSEcCtD
Etoposide—Diarrhoea—Epirubicin—breast cancer	4.76e-06	7.16e-05	CcSEcCtD
Etoposide—Hypersensitivity—Doxorubicin—breast cancer	4.74e-06	7.14e-05	CcSEcCtD
Etoposide—Vomiting—Methotrexate—breast cancer	4.73e-06	7.11e-05	CcSEcCtD
Etoposide—Rash—Methotrexate—breast cancer	4.69e-06	7.05e-05	CcSEcCtD
Etoposide—Dermatitis—Methotrexate—breast cancer	4.68e-06	7.05e-05	CcSEcCtD
Etoposide—Headache—Methotrexate—breast cancer	4.66e-06	7.01e-05	CcSEcCtD
Etoposide—Asthenia—Doxorubicin—breast cancer	4.62e-06	6.95e-05	CcSEcCtD
Etoposide—Dizziness—Epirubicin—breast cancer	4.6e-06	6.92e-05	CcSEcCtD
Etoposide—Pruritus—Doxorubicin—breast cancer	4.56e-06	6.85e-05	CcSEcCtD
Etoposide—Vomiting—Epirubicin—breast cancer	4.42e-06	6.66e-05	CcSEcCtD
Etoposide—Nausea—Methotrexate—breast cancer	4.42e-06	6.64e-05	CcSEcCtD
Etoposide—Diarrhoea—Doxorubicin—breast cancer	4.41e-06	6.63e-05	CcSEcCtD
Etoposide—Rash—Epirubicin—breast cancer	4.39e-06	6.6e-05	CcSEcCtD
Etoposide—Dermatitis—Epirubicin—breast cancer	4.38e-06	6.59e-05	CcSEcCtD
Etoposide—Headache—Epirubicin—breast cancer	4.36e-06	6.56e-05	CcSEcCtD
Etoposide—Dizziness—Doxorubicin—breast cancer	4.26e-06	6.4e-05	CcSEcCtD
Etoposide—Nausea—Epirubicin—breast cancer	4.13e-06	6.22e-05	CcSEcCtD
Etoposide—Vomiting—Doxorubicin—breast cancer	4.09e-06	6.16e-05	CcSEcCtD
Etoposide—Rash—Doxorubicin—breast cancer	4.06e-06	6.11e-05	CcSEcCtD
Etoposide—Dermatitis—Doxorubicin—breast cancer	4.06e-06	6.1e-05	CcSEcCtD
Etoposide—Headache—Doxorubicin—breast cancer	4.03e-06	6.07e-05	CcSEcCtD
Etoposide—Nausea—Doxorubicin—breast cancer	3.82e-06	5.75e-05	CcSEcCtD
Etoposide—CYP2C8—Metabolism—GSTP1—breast cancer	6.67e-07	1.71e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—ERCC2—breast cancer	6.67e-07	1.71e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NAT2—breast cancer	6.67e-07	1.71e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—MTHFR—breast cancer	6.66e-07	1.7e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—ERCC2—breast cancer	6.66e-07	1.7e-05	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	6.65e-07	1.7e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PIK3CB—breast cancer	6.63e-07	1.7e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—CDKN1A—breast cancer	6.61e-07	1.69e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—EGF—breast cancer	6.61e-07	1.69e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—PTEN—breast cancer	6.59e-07	1.69e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—HMOX1—breast cancer	6.58e-07	1.68e-05	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—AKT1—breast cancer	6.57e-07	1.68e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ITPR1—breast cancer	6.57e-07	1.68e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PTGS2—breast cancer	6.57e-07	1.68e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—HSP90AA1—breast cancer	6.55e-07	1.68e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CD—breast cancer	6.45e-07	1.65e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PIK3CB—breast cancer	6.39e-07	1.64e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—NCOA1—breast cancer	6.38e-07	1.63e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—ALB—breast cancer	6.37e-07	1.63e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP17A1—breast cancer	6.34e-07	1.62e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PTGS2—breast cancer	6.33e-07	1.62e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ABCB1—breast cancer	6.32e-07	1.62e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CYP19A1—breast cancer	6.28e-07	1.61e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—STK11—breast cancer	6.28e-07	1.61e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—BRAF—breast cancer	6.28e-07	1.61e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ENO1—breast cancer	6.28e-07	1.61e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PTGS1—breast cancer	6.28e-07	1.61e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—MTHFR—breast cancer	6.27e-07	1.6e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—MTHFR—breast cancer	6.26e-07	1.6e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	6.25e-07	1.6e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—TYMS—breast cancer	6.21e-07	1.59e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CD—breast cancer	6.2e-07	1.59e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	6.17e-07	1.58e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP2D6—breast cancer	6.15e-07	1.57e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CAV1—breast cancer	6.15e-07	1.57e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—NCOR1—breast cancer	6.13e-07	1.57e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PLA2G4A—breast cancer	6.13e-07	1.57e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GSTM1—breast cancer	6.13e-07	1.57e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—ALB—breast cancer	6.12e-07	1.57e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—SRC—breast cancer	6.12e-07	1.56e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—AKT2—breast cancer	6.12e-07	1.56e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—NOS3—breast cancer	6.09e-07	1.56e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—NCOA2—breast cancer	6.04e-07	1.55e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—STAT3—breast cancer	5.9e-07	1.51e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PIK3CD—breast cancer	5.88e-07	1.5e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GPX1—breast cancer	5.87e-07	1.5e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	5.87e-07	1.5e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—FASN—breast cancer	5.86e-07	1.5e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—NOS3—breast cancer	5.85e-07	1.5e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—DPYD—breast cancer	5.84e-07	1.5e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—MED12—breast cancer	5.84e-07	1.5e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—COMT—breast cancer	5.84e-07	1.49e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—BCHE—breast cancer	5.83e-07	1.49e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GSTP1—breast cancer	5.81e-07	1.49e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CYP1A1—breast cancer	5.81e-07	1.49e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—SERPINE1—breast cancer	5.81e-07	1.49e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CAV1—breast cancer	5.78e-07	1.48e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CAV1—breast cancer	5.77e-07	1.48e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ERCC2—breast cancer	5.77e-07	1.48e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—SLC5A5—breast cancer	5.76e-07	1.47e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ALDOA—breast cancer	5.75e-07	1.47e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—HMOX1—breast cancer	5.73e-07	1.47e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PTEN—breast cancer	5.73e-07	1.47e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—ITPR1—breast cancer	5.72e-07	1.46e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—MAPK3—breast cancer	5.63e-07	1.44e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CB—breast cancer	5.62e-07	1.44e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CG—breast cancer	5.6e-07	1.43e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NCOA3—breast cancer	5.59e-07	1.43e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PTGS2—breast cancer	5.57e-07	1.43e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—SLC2A1—breast cancer	5.57e-07	1.42e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—NQO1—breast cancer	5.57e-07	1.42e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—NOS3—breast cancer	5.55e-07	1.42e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—SLC2A2—breast cancer	5.55e-07	1.42e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PTEN—breast cancer	5.52e-07	1.41e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—MYC—breast cancer	5.48e-07	1.4e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—TGFB1—breast cancer	5.47e-07	1.4e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	5.45e-07	1.39e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CPT1A—breast cancer	5.43e-07	1.39e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—MTR—breast cancer	5.43e-07	1.39e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ABCG2—breast cancer	5.43e-07	1.39e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP3A4—breast cancer	5.43e-07	1.39e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—MTHFR—breast cancer	5.42e-07	1.39e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—TYMS—breast cancer	5.41e-07	1.38e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CB—breast cancer	5.4e-07	1.38e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	5.4e-07	1.38e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—EGFR—breast cancer	5.36e-07	1.37e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PTGS2—breast cancer	5.35e-07	1.37e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—NCOR1—breast cancer	5.34e-07	1.37e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PLA2G4A—breast cancer	5.34e-07	1.37e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GSTM1—breast cancer	5.34e-07	1.37e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP1B1—breast cancer	5.34e-07	1.37e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—HPGDS—breast cancer	5.33e-07	1.36e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—HBA1—breast cancer	5.3e-07	1.35e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CG—breast cancer	5.27e-07	1.35e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MDM2—breast cancer	5.26e-07	1.35e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CG—breast cancer	5.26e-07	1.35e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—RAF1—breast cancer	5.25e-07	1.34e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—HSP90AA1—breast cancer	5.23e-07	1.34e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—ERBB2—breast cancer	5.19e-07	1.33e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTT1—breast cancer	5.17e-07	1.32e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ACHE—breast cancer	5.17e-07	1.32e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MTOR—breast cancer	5.12e-07	1.31e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PIK3CB—breast cancer	5.12e-07	1.31e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GPX1—breast cancer	5.12e-07	1.31e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CD4—breast cancer	5.11e-07	1.31e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—NCOA1—breast cancer	5.09e-07	1.3e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CYP1A1—breast cancer	5.07e-07	1.3e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—KRAS—breast cancer	5.06e-07	1.3e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—ERCC2—breast cancer	5.02e-07	1.29e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP19A1—breast cancer	5.02e-07	1.28e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—STK11—breast cancer	5.02e-07	1.28e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CAV1—breast cancer	5e-07	1.28e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PIK3CA—breast cancer	4.97e-07	1.27e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CD—breast cancer	4.92e-07	1.26e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP17A1—breast cancer	4.89e-07	1.25e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PTEN—breast cancer	4.86e-07	1.24e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—ALB—breast cancer	4.86e-07	1.24e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ENO1—breast cancer	4.84e-07	1.24e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PTGS1—breast cancer	4.84e-07	1.24e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CDKN1B—breast cancer	4.81e-07	1.23e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.78e-07	1.22e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP2D6—breast cancer	4.75e-07	1.22e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—MTHFR—breast cancer	4.72e-07	1.21e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.71e-07	1.2e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PTEN—breast cancer	4.67e-07	1.19e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—COMT—breast cancer	4.66e-07	1.19e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NCOA2—breast cancer	4.66e-07	1.19e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—PIK3CA—breast cancer	4.65e-07	1.19e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—NOS3—breast cancer	4.65e-07	1.19e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GSTP1—breast cancer	4.64e-07	1.19e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CD—breast cancer	4.63e-07	1.19e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CD—breast cancer	4.62e-07	1.18e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—HMOX1—breast cancer	4.58e-07	1.17e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—ALB—breast cancer	4.57e-07	1.17e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ITPR1—breast cancer	4.57e-07	1.17e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—ALB—breast cancer	4.56e-07	1.17e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CG—breast cancer	4.55e-07	1.17e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CTNNB1—breast cancer	4.54e-07	1.16e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—FASN—breast cancer	4.52e-07	1.16e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—BCHE—breast cancer	4.5e-07	1.15e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—SLC5A5—breast cancer	4.45e-07	1.14e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CDKN1A—breast cancer	4.44e-07	1.13e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PTEN—breast cancer	4.43e-07	1.13e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ABCB1—breast cancer	4.39e-07	1.12e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—NOS3—breast cancer	4.37e-07	1.12e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—NOS3—breast cancer	4.36e-07	1.12e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CAV1—breast cancer	4.36e-07	1.11e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—TYMS—breast cancer	4.32e-07	1.1e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—HRAS—breast cancer	4.3e-07	1.1e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NQO1—breast cancer	4.3e-07	1.1e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—SLC2A1—breast cancer	4.3e-07	1.1e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CB—breast cancer	4.29e-07	1.1e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PLA2G4A—breast cancer	4.27e-07	1.09e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—NCOR1—breast cancer	4.27e-07	1.09e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GSTM1—breast cancer	4.27e-07	1.09e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—IL6—breast cancer	4.12e-07	1.05e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP1B1—breast cancer	4.12e-07	1.05e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—SRC—breast cancer	4.1e-07	1.05e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GPX1—breast cancer	4.09e-07	1.05e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—AKT1—breast cancer	4.06e-07	1.04e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP1A1—breast cancer	4.04e-07	1.03e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PIK3CA—breast cancer	4.04e-07	1.03e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—HSP90AA1—breast cancer	4.04e-07	1.03e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CB—breast cancer	4.04e-07	1.03e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CB—breast cancer	4.03e-07	1.03e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ERCC2—breast cancer	4.01e-07	1.03e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CD—breast cancer	4e-07	1.02e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PTGS2—breast cancer	4e-07	1.02e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PTGS2—breast cancer	3.99e-07	1.02e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CG—breast cancer	3.97e-07	1.02e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—STAT3—breast cancer	3.96e-07	1.01e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ALB—breast cancer	3.95e-07	1.01e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NCOA1—breast cancer	3.93e-07	1.01e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PIK3CA—breast cancer	3.9e-07	9.97e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—STK11—breast cancer	3.87e-07	9.91e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP19A1—breast cancer	3.87e-07	9.91e-06	CbGpPWpGaD
Etoposide—ABCC1—Disease—AKT1—breast cancer	3.8e-07	9.72e-06	CbGpPWpGaD
Etoposide—PTGS2—Disease—MAPK3—breast cancer	3.78e-07	9.67e-06	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—NOS3—breast cancer	3.78e-07	9.67e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—MTHFR—breast cancer	3.77e-07	9.65e-06	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PTEN—breast cancer	3.71e-07	9.48e-06	CbGpPWpGaD
Etoposide—PTGS2—Disease—MYC—breast cancer	3.68e-07	9.41e-06	CbGpPWpGaD
Etoposide—PTGS2—Disease—TGFB1—breast cancer	3.67e-07	9.39e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—COMT—breast cancer	3.6e-07	9.21e-06	CbGpPWpGaD
Etoposide—PTGS2—Disease—EGFR—breast cancer	3.6e-07	9.2e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTP1—breast cancer	3.58e-07	9.17e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—HMOX1—breast cancer	3.53e-07	9.04e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ITPR1—breast cancer	3.53e-07	9.02e-06	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CB—breast cancer	3.49e-07	8.93e-06	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PTEN—breast cancer	3.49e-07	8.93e-06	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CD—breast cancer	3.49e-07	8.92e-06	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PTEN—breast cancer	3.48e-07	8.91e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CAV1—breast cancer	3.48e-07	8.9e-06	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PTGS2—breast cancer	3.46e-07	8.85e-06	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—ALB—breast cancer	3.44e-07	8.81e-06	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CA—breast cancer	3.43e-07	8.77e-06	CbGpPWpGaD
Etoposide—PTGS2—Disease—KRAS—breast cancer	3.4e-07	8.69e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ABCB1—breast cancer	3.39e-07	8.68e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—TYMS—breast cancer	3.33e-07	8.52e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.32e-07	8.5e-06	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—AKT1—breast cancer	3.3e-07	8.44e-06	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—NOS3—breast cancer	3.29e-07	8.43e-06	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CA—breast cancer	3.29e-07	8.43e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NCOR1—breast cancer	3.29e-07	8.42e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PLA2G4A—breast cancer	3.29e-07	8.42e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTM1—breast cancer	3.29e-07	8.42e-06	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—AKT1—breast cancer	3.18e-07	8.14e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CG—breast cancer	3.17e-07	8.1e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GPX1—breast cancer	3.15e-07	8.07e-06	CbGpPWpGaD
Etoposide—PTGS2—Disease—PIK3CA—breast cancer	3.12e-07	7.99e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP1A1—breast cancer	3.12e-07	7.99e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ERCC2—breast cancer	3.1e-07	7.92e-06	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CB—breast cancer	3.04e-07	7.78e-06	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PTEN—breast cancer	3.02e-07	7.72e-06	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PTGS2—breast cancer	3.01e-07	7.71e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—MTHFR—breast cancer	2.91e-07	7.44e-06	CbGpPWpGaD
Etoposide—PTGS2—Disease—HRAS—breast cancer	2.89e-07	7.39e-06	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—AKT1—breast cancer	2.8e-07	7.17e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CD—breast cancer	2.78e-07	7.12e-06	CbGpPWpGaD
Etoposide—PTGS2—Disease—IL6—breast cancer	2.76e-07	7.07e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ALB—breast cancer	2.75e-07	7.03e-06	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—AKT1—breast cancer	2.69e-07	6.88e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CAV1—breast cancer	2.68e-07	6.87e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—NOS3—breast cancer	2.63e-07	6.73e-06	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PTEN—breast cancer	2.63e-07	6.72e-06	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CA—breast cancer	2.61e-07	6.69e-06	CbGpPWpGaD
Etoposide—PTGS2—Disease—AKT1—breast cancer	2.55e-07	6.53e-06	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CA—breast cancer	2.46e-07	6.3e-06	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CA—breast cancer	2.46e-07	6.28e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CG—breast cancer	2.44e-07	6.25e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CB—breast cancer	2.43e-07	6.21e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PTGS2—breast cancer	2.4e-07	6.15e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CD—breast cancer	2.15e-07	5.5e-06	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—AKT1—breast cancer	2.14e-07	5.46e-06	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CA—breast cancer	2.13e-07	5.44e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ALB—breast cancer	2.12e-07	5.43e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PTEN—breast cancer	2.1e-07	5.37e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NOS3—breast cancer	2.03e-07	5.19e-06	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—AKT1—breast cancer	2.01e-07	5.14e-06	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—AKT1—breast cancer	2.01e-07	5.13e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CB—breast cancer	1.87e-07	4.79e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PTGS2—breast cancer	1.86e-07	4.75e-06	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CA—breast cancer	1.85e-07	4.74e-06	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—AKT1—breast cancer	1.74e-07	4.45e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PTEN—breast cancer	1.62e-07	4.14e-06	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—AKT1—breast cancer	1.51e-07	3.87e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CA—breast cancer	1.48e-07	3.79e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—AKT1—breast cancer	1.21e-07	3.09e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CA—breast cancer	1.14e-07	2.92e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—AKT1—breast cancer	9.33e-08	2.39e-06	CbGpPWpGaD
